Phase 2 Lung Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who are able to give written agreement to participate and can understand and follow the study requirements and visit schedule.
- People who are male or female, aged 18 years or older and under 80 years old at the time of signing the consent form.
- People who have been confirmed through tissue or cell testing to have advanced lung cancer (stage III or stage IV, based on standard medical staging guidelines).
- People who were diagnosed with high blood pressure before their advanced lung cancer diagnosis.
- People whose general health and ability to carry out daily activities meets a certain level of fitness (a score of 0 or 1 on a standard medical scale used to measure this).
- People who have adequately functioning organs at the time of their screening assessment.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People whose expected survival is predicted to be less than 12 months.
- People who are pregnant at the time of the trial.
- People who have had an allergic reaction or sensitivity to any ingredient in the study medication (ARNI).
- People with severely reduced kidney function (as measured by a specific blood test result below a certain threshold).
- People with severe liver disease (classified at a specific level of severity on a standard medical scale).
- People who have narrowing of the arteries supplying both kidneys, or narrowing in the artery supplying a single kidney.
- People with persistently high potassium levels in the blood that are difficult to treat.
- People with moderate or severe narrowing of the aortic heart valve.
- People with a heart muscle condition where the heart wall is abnormally thickened, causing a blockage to blood flow.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
All-cause mortality
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.